Produktinformation
- 1-Methyl-N-[4-[[(2S)-2-[2-(4-morpholinyl)ethyl]-1-piperidinyl]sulfonyl]phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
Applications ERDRP-0519 is a novel orally available polymerase inhibitor, showing efficacy against a lethal morbillivirus Infection in a large animal model.
References Krumm, Stefanie A., et al.: Sci. Transl. Med., 6, 232 (2014);